WHO ICTRP trial
Study of a vaginal treatment in preventing Recurrent Vulvovaginal Candidiasis…
ACTRN12620001084976 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Not Recruiting
Key facts
| Trial ID | ACTRN12620001084976 |
|---|---|
| Public title | Study of a vaginal treatment in preventing Recurrent Vulvovaginal Candidiasis (thrush) |
| Scientific title | Efficacy of Intravaginal Combination Therapy of Acetic and Lactic Acid (ICTALA) in premenopausal women with Recurrent Vulvovaginal Candidiasis – A Randomised, Double blind Placebo Controlled Clinical Feasibility Trial |
| Primary sponsor | Griffith Univeristy |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2 |
| Countries | Australia |
| Conditions | Recurrent Vulvovaginal Candidiasis ; Recurrent Vulvovaginal Candidiasis ;Infection - Other infectious diseases;Alternative and Complementary Medicine - Other alternative and complementary medicine;Renal and Urogenital - Other renal and… |
| Interventions | A 1.9gm pessary that contains 3% Acetic and 2% lactic acid in gelatin forms the investigational medicinal product. Intravaginal Combination Therapy of Acetic and Lactic Acid (ICTALA) One ICTALA pessary, applied for 7 days following… |
| Registration date | Oct 20, 2020 |
| Target size | 128 |
| Secondary IDs | NIL |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: